- Health
- 16 views
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images The…
- Health
- 0 views
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters The Food and Drug Administration on…
- Health
- 13 views
Why Americans are outraged over health insurance — and what could change
A person holds a sign while standing on the roadside near the McDonald’s restaurant where a suspect in the killing of the CEO of UnitedHealthcare, Brian Thompson, identified as Luigi…
- Health
- 9 views
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Wednesday said it has snagged the rights…
- Health
- 11 views
Health AI startup Suki expands partnership with Google Cloud to deliver more assistive tech for clinicians
Health-care artificial intelligence startup Suki on Wednesday announced a new collaboration with Google Cloud as part of its push to expand beyond clinical documentation. Through the partnership, Suki is building…
- Health
- 9 views
Healthy Returns: Novo Nordisk’s Ozempic faces scrutiny over potential link to rare eye condition
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared…
- Health
- 9 views
Dexcom’s over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Dexcom on Tuesday announced an artificial intelligence…
- Health
- 0 views
We’re adding to our position in a stock that just landed a big Wall Street endorsement
Shortly after the opening the bell, we will be buying 300 shares of Bristol Myers Squibb at roughly $56.50. Following the trade, Jim Cramer’s Charitable Trust will own 1,200 shares…
- Health
- 0 views
UnitedHealth Group CEO addresses Brian Thompson death, says health-care system is ‘flawed’
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America’s Health Care: Assessing the Change Healthcare Cyber Attack and What’s Next,” in the Dirksen…
- Health
- 0 views
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters Prescription fills for blockbuster weight loss drugs…
